Sanofi Research and Development Expenses 2012-2026 | SNY

Sanofi research and development expenses for the twelve months ending March 31, 2026 were $9.012B, a 12.1% increase year-over-year.

  • Sanofi annual research and development expenses for 2025 were $8.872B, a 10.89% increase from 2024.
  • Sanofi annual research and development expenses for 2024 were $8.001B, a 9.88% increase from 2023.
  • Sanofi annual research and development expenses for 2023 were $7.282B, a 3.06% increase from 2022.

Sanofi Research and Development Expenses 2012-2026 | SNY

  • Sanofi annual research and development expenses for 2025 were $8.872B, a 10.89% increase from 2024.
  • Sanofi annual research and development expenses for 2024 were $8.001B, a 9.88% increase from 2023.
  • Sanofi annual research and development expenses for 2023 were $7.282B, a 3.06% increase from 2022.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$887.6B
Johnson & Johnson (JNJ)$574.4B
AbbVie (ABBV)$367.7B
Roche Holding AG (RHHBY)$318.8B
Merck (MRK)$299.9B
Novartis AG (NVS)$294B
Novo Nordisk (NVO)$167.5B
Pfizer (PFE)$153.1B
Bayer (BAYRY)$46.2B
Innoviva (INVA)$1.8B